Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 176 participants.
Also called NCT01173809
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 176 participants
- Sponsor
- Registry
-
NCT01173809
-
- Other papers using this trial's data
- Effect of periprocedural amiodarone on procedure outcome in patients with longstanding persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: results from a randomized study (SPECULATE)
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01173809. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2014-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral Isolation
- Acronym
- SPECULATE
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Amiodarone
- Intervention (Drug)
- Amiodarone
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Collaborator
- University of Kansas
- Collaborator
- California Pacific Medical Center
- Collaborator
- Stanford University
- Collaborator
- Case Western Reserve University
- Collaborator
- Southlake Health
- Collaborator
- Catholic University, Italy
Record details
- Record id
cardio:ct-nct01173809- Content hash
2eca44951a00c5caac9afe77e481dcdd1180140af69d10dfc6eba3ca84ac74ce